NARAFLOX

This brand name is authorized in Nigeria.

Active ingredients

The drug NARAFLOX contains one active pharmaceutical ingredient (API):

1	Levofloxacin UNII 6GNT3Y5LMF - LEVOFLOXACIN
	Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV.
	Read more about Levofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-6433	Tablet	NARAFLOX TABLET TAB 500 mg 1 X 10	51 RNW-PP-214201 NARAFLOX TABLET LEVOFLOXACIN USP 500MG LEVOFLOXACIN 500MG, HEMIHYDRATE USP, CROSCARMELLOSE SODIUM, MAIZE STARCH, PURIFIED TALC, MAGNESIUM STEARATE, SODIUM STARCH GLYCOLATE, MICROCRYSTALLINE CELLULOSE SUNSET YELLOW B4-6433 Drugs Imported Products 1X10 Prescription Only Medicine (POM) 6/9/2021 MAYDON PHARMACEUTICAL LIMITED., WILMER STREET, OFF TOWN PLANNING, ILUPEJU, LAGOS LAGOS 1740194511 maydonp@outlook.com BAROQUE PHARMACEUTICALS PVT, LTD., , 192/2/3, SOKHADA-388620, TA. KHAMBHAT DISTRICT. ANAND, GUJARAT STATE, INDIA., India	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA12	Levofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-6433